Q4 2021 13F Holders as of 31 Dec 2021
-
Type / Class
-
Equity / COM NEW
-
Total 13F shares
-
11,001,994
-
Share change
-
+553,177
-
Total reported value
-
$239,177,435
-
Price per share
-
$21.74
-
Number of holders
-
44
-
Value change
-
+$12,003,735
-
Number of buys
-
24
-
Number of sells
-
10
Institutional Holders of SIERRA ONCOLOGY INC - COM NEW (SRRA) as of Q4 2021
As of 31 Dec 2021 SIERRA ONCOLOGY INC - COM NEW (SRRA) had 44 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 11,001,994 shares of stock of the company.
Largest 10 holders included Vivo Capital, LLC, ORBIMED ADVISORS LLC, FRAZIER MANAGEMENT LLC, ADAGE CAPITAL PARTNERS GP, L.L.C., Rock Springs Capital Management LP, Deep Track Capital, LP, Ikarian Capital, LLC, Paradigm Biocapital Advisors LP, VANGUARD GROUP INC, and CAXTON CORP.
This table shows 44 institutional shareholders of the security as of 31 Dec 2021.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.